12:00 AM
 | 
Feb 11, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Medgenics completes follow-on

Medgenics Inc. (LSE:MEDU; NYSE-M:MDGN), Vienna, Va.
Business: Gene/Cell therapy, Drug delivery
Date completed: 2/8/13
Type: Follow-on
Raised: $29.4 million
Units: 5.6...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >